On July 19, 2023, LINKS officially established its office in Tianjin. This is the tenth office established by LINKS after its headquarters in Shanghai, branches in Beijing, Guangzhou, Shenzhen as well as branches in Nanjing, Wuhan, Chengdu, Zhengzhou, and Xi’an. The addition of the Tianjin office marks another important milestone in LINKS' national layout, which will further enhance the company's regional radiation range and service capabilities.
(Tianjin Office: A413, Xinzhengcheng Entrepreneurship Park, No. 27 Dongting Road, Chentangzhuang, Hexi District, Tianjin)
Since its establishment in 2014, LINKS has achieved significant milestones in the medical device industry in China. In just a few years, it has become the youngest council member of the Clinical Trial Sub-Association of the China Association for Medical Devices Industry (CAMDI). LINKS has also obtained BSI quality certification, high-tech enterprise certification, and received honors such as "Innovative Technology Enterprise," "High-Quality Enterprise," and "SRDI (Specialized, Refinement, Differential, Innovation)". Even during the challenges posed by the COVID-19 pandemic over the past three years, LINKS has not halted its growth and continues to expand both domestically and globally. The team has grown significantly, with nearly 200 employees, of which over 85% are technical professionals.
Tianjin, known as the "City of Nine Rivers" and "Gateway to the Sea and Rivers," is hailed as the "Pearl of the Bohai Sea" and a crucial juncture for river and sea transport. As an important northern city in China, Tianjin boasts advantageous geographical location and excellent transportation conditions. Moreover, LINKS already has project collaborations with key hospitals in Tianjin. The name LINKS signifies "connecting" and aims to be the bridge linking sponsors, research institutions, and investigators. Through a comprehensive service system and leading quality standards, LINKS provides professional services to enterprises, helping them improve research and development efficiency, reduce registration risks, and ensure high-quality project delivery. Choosing Tianjin as the location for the tenth office will undoubtedly better and faster connect various parties, respond to customer needs, and accelerate the commercialization of medical devices.
LINKS currently has employees stationed in nearly 30 cities across the country, including Tianjin. The establishment of the Tianjin office is expected to enhance the sense of belonging and increase team cohesion among the local employees. LINKS will continue to serve customers with a “professional, efficient, win-win, and sustainable development” attitude, solving problems and creating value.
Through the ups and downs, LINKS has flourished over the years. After years of hard work, we have achieved fruitful results. As we enter the tenth year and establish our tenth office, we wish LINKS to navigate through any challenges with ease and continue to forge ahead. May nothing hinder our progress as we embark on a new journey, composing a new chapter!
LINKS CRO
As a CRO company providing clinical trial services. LINKS CRO focus on innovation, high-risk implantation(intervention) medical device, with one-stop clinical trial solutions for the whole process of medical device research and development.The headquarters of LINKS is based in Shanghai, with subsidiary branches in Beijing, Shanghai, Guangzhou, and Shenzhen, in addition to ten regional offices. The current workforce comprises almost 200 employees, with technical personnel making up over 85% and dispersed across almost 30 cities nationwide.
Key Services include CRO, SMO, CER, Audit, Post-market research, core laboratory registration both domestically and overseas, innovation declaration, Expert Consultancy, and overseas enterprise agency services.
Key Indications include Cardiovascular, Neurovascular, Peripheral Vascular, Surgery Robot, Oncology, Ophthalmology, Medical Cosmetology, and other fields such as orthopedics. There are almost 300 projects consultations and services by LINKS each year.